This area of the Portal requires a log in.
The Clinical Practice Guideline development panel for Allergic Rhinitis has identified a list of potential quality improvement topics which will be narrowed to 10-15 key action statements (blind voting by the panel) that will make up the framework for the guideline. This draft will be available for public comment for a two week period beginning October 1 though October 15, 2013. To participate in the public comment, users will be required to agree to a confidentiality statement and complete a confilct of interet disclosure.
The document will include the guideline scope and list of potential quality improvement topics. Once public reviewers have downloaded the document, they will be emailed a link to return to the site to enter their comments, after they have had an opportunity to review the document.
The purpose of the comment period is to ensure that all pertinent stakeholders, including the public, have an opportunity to review the guideline’s scope and potential quality improvement topics to ensure that nothing is left out. All comments received will be reviewed by the guideline development group. Any additional topics that are suggested during the public comment period will be added to the topic list; which will be ranked by the guideline panel to help narrow the list down to 10-15 key action statements. Please note that the guideline panel will not be providing responses to comments received; if necessary, individuals may be contacted for comment clarification.
If you have any problems logging in with your username and password, please contact Lorraine Nnacheta email@example.com or Phone: 703-535-3751.
If you are a member and know your login Click Here
To retrieve your password Click Here
To create a login account Click Here
If you have any questions or problems please email firstname.lastname@example.org